Ohinata Hironori, Miyashita Mitsunori, Maeda Isseki
Faculty of Health Sciences (H.O.), Hokkaido University, Sapporo, Japan.
Department of Palliative Nursing Health Sciences (M.M.), Tohoku University Graduate School of Medicine, Miyagi , Japan.
J Pain Symptom Manage. 2025 Oct;70(4):371-378.e2. doi: 10.1016/j.jpainsymman.2025.07.007. Epub 2025 Jul 12.
International guidelines recommend specialized palliative care for patients with complex care needs. However, scales assessing patient complexity should be modified according to each country and its healthcare systems.
This study aimed to develop a scale for assessing the complexity of palliative care needs among patients referred to a palliative care unit and to determine its validity.
We developed an 8-item COMPLEX scale (with each item scored 0-3 points) to assess patient complexity based on physicians' clinical reasoning and a literature review. Data were collected from a palliative care unit at a Japanese hospital between September 2022 and March 2023. The inclusion criteria were: (1) referral to a palliative care unit, and (2) any age, sex, or primary cancer focus.
A total of 305 patients were included in the analysis. During the data collection period, 148 patients (48.5%) died. Regarding survival time analysis, patients were stratified into three groups based on their COMPLEX scale scores. At the time of referral to the palliative care unit, the mean survival time was 62.0 days for those with a score of ≤8, 51.1 days for those with scores of 9-10, and 48.8 days for those with a score of ≥11. Overall, patients with higher scores had significantly shorter survival times than those with lower scores (P = 0.037).
The COMPLEX scale demonstrated meaningful associations with external indicators, such as survival time. Future studies should validate its reliability across diverse clinical settings, among various raters, and in relation to other external indicators.
国际指南推荐为有复杂护理需求的患者提供专科姑息治疗。然而,评估患者复杂性的量表应根据每个国家及其医疗保健系统进行调整。
本研究旨在开发一种量表,用于评估转诊至姑息治疗病房的患者的姑息治疗需求复杂性,并确定其有效性。
我们基于医生的临床推理和文献综述,开发了一个包含8个条目的COMPLEX量表(每个条目得分0-3分)来评估患者复杂性。2022年9月至2023年3月期间,从日本一家医院的姑息治疗病房收集数据。纳入标准为:(1)转诊至姑息治疗病房;(2)任何年龄、性别或原发癌症部位。
共有305例患者纳入分析。在数据收集期间,148例患者(48.5%)死亡。关于生存时间分析,根据COMPLEX量表得分将患者分为三组。在转诊至姑息治疗病房时,得分≤8分的患者平均生存时间为62.0天,得分9-10分的患者为51.1天,得分≥11分的患者为48.8天。总体而言,得分较高的患者生存时间明显短于得分较低的患者(P = 0.037)。
COMPLEX量表与生存时间等外部指标显示出有意义的关联。未来的研究应在不同临床环境、不同评分者中以及与其他外部指标相关的情况下验证其可靠性。